Literature DB >> 12869458

Cirrhosis: new research provides a basis for rational and targeted treatments.

John P Iredale1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869458      PMCID： PMC1126509          DOI： 10.1136/bmj.327.7407.143

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

1.  Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo.

Authors:  J J Maher; R F McGuire
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

Authors:  S L Friedman; F J Roll; J Boyles; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.

Authors:  J George; D Roulot; V E Koteliansky; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

Authors:  R C Benyon; J P Iredale; S Goddard; P J Winwood; M J Arthur
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

Review 5.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

Review 6.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

7.  Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells.

Authors:  S C Wang; M Ohata; L Schrum; R A Rippe; H Tsukamoto
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

8.  Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis.

Authors:  K Thompson; J Maltby; J Fallowfield; M McAulay; H Millward-Sadler; N Sheron
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

9.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

10.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808
View more
  39 in total

Review 1.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 2.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

3.  Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation.

Authors:  J Michael Estep; Linda O'Reilly; Geraldine Grant; James Piper; Johann Jonsson; Arian Afendy; Vikas Chandhoke; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2009-08-13       Impact factor: 3.199

4.  Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo.

Authors:  M Niiya; M Uemura; X W Zheng; E S Pollak; M Dockal; F Scheiflinger; R G Wells; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

5.  Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.

Authors:  Li-Jen Su; Shih-Lan Hsu; Jyh-Shyue Yang; Huei-Hun Tseng; Shiu-Feng Huang; Chi-Ying F Huang
Journal:  Gene Expr       Date:  2006

6.  Low frequency magnetic force augments hepatic differentiation of mesenchymal stem cells on a biomagnetic nanofibrous scaffold.

Authors:  Dillip Kumar Bishi; Soma Guhathakurta; Jayarama Reddy Venugopal; Kotturathu Mammen Cherian; Seeram Ramakrishna
Journal:  J Mater Sci Mater Med       Date:  2014-07-11       Impact factor: 3.896

7.  Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury.

Authors:  Soo Young Park; Hye Won Shin; Kyoung Bun Lee; Min-Jae Lee; Ja-June Jang
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

8.  Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner.

Authors:  Ping Liu; Mi Wang; Xiao-Dan Lu; Shu-Juan Zhang; Wang-Xian Tang
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Steven F Bronk; Sophie Cazanave; Nathan W Werneburg; Justin L Mott; Patricia C Contreras; Gregory J Gores
Journal:  Hepatol Res       Date:  2009-07-13       Impact factor: 4.288

10.  Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice.

Authors:  Keitaro Tashiro; Ayano Satoh; Teruo Utsumi; Chuhan Chung; Yasuko Iwakiri
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.